SEC Form 4 · accession 0001493152-16-008576
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deina H Walsh
Officer — Chief Financial Officer
Period of report
Mar 25, 2016
Accepted (ET)
Mar 31, 2016 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | $0.00 | Mar 25, 2016 | A | 11,104 | A | — | — | Common Stock | 11,104 | 11,104 | D |
Explanation of responses
- F1On March 25, 2016, the Reporting Person was granted 11,104 shares of restricted stock, which fully vest on March 25, 2020, provided the Reporting Person is still providing services to the Issuer on the respective date.